The Mesothelioma Center News
Mesothelioma Surgery with Organ Removal Extends Survival
- by Tim Povtak
- Treatment & Doctors
- Nov 17, 2020
Removing major organs to achieve a more complete cancer resection did not increase severe complications or hinder survival benefits of aggressive surgery for patients with peritoneal mesothelioma, according to…
Read More
Latest T-Cell Clinical Trial Opens for Mesothelioma Patients
- by Tim Povtak
- Research & Clinical Trials
- Oct 8, 2020
Memorial Sloan Kettering Cancer Center in New York City has begun recruiting patients with pleural mesothelioma for its latest — and potentially most promising — clinical trial involving T-cell…
Read More
Congress Fails to Vote on Asbestos Ban Legislation
- by Tim Povtak
- Asbestos Exposure & Bans
- Oct 7, 2020
The U.S. House of Representatives last week failed to advance once-promising legislation that effectively would have banned asbestos, frustrating advocates once again. H.R. 1603, titled the Alan Reinstein Ban…
Read More
Johnson & Johnson Will Pay $100M in Baby Powder Lawsuits
- by Tim Povtak
- Legislation & Litigation
- Oct 6, 2020
Pharmaceutical giant Johnson & Johnson has agreed to pay more than $100 million to settle more than a thousand lawsuits claiming its iconic talc-based baby powder caused cancer, according to…
Read More
FDA Approves Opdivo, Yervoy Combination for Mesothelioma
- by Tim Povtak
- Treatment & Doctors
- Oct 5, 2020
The U.S. Food and Drug Administration has approved the immunotherapy combination of Opdivo and Yervoy for first-line treatment of unresectable malignant pleural mesothelioma. It was the first new drug…
Read More
KCIC Report: Mesothelioma Lawsuits on the Rise in US
- by Tim Povtak
- Legislation & Litigation
- Sep 29, 2020
While the incidence of malignant mesothelioma in the United States continued its gradual decline, the tendency to sue for damages drastically increased in recent years, according to a KCIC study.
Read More
Gene Therapy Clinical Trial for Mesothelioma Moving Forward
- by Tim Povtak
- Research & Clinical Trials
- Sep 23, 2020
A much-anticipated, phase III clinical trial studying the use of gene therapy to combat pleural mesothelioma cancer has made a promising start. Interest is growing in what many believe…
Read More
Mesothelioma Trial to Test Cancer Vaccine with Immunotherapy
- by Tim Povtak
- Research & Clinical Trials
- Sep 14, 2020
A research team at Oslo University Hospital in Norway has opened a mesothelioma clinical trial using the novel UV1 cancer vaccine alongside a promising immunotherapy combination. UV1 is a…
Read More
Peer Review Finds EPA’s Asbestos Risk Evaluation Flawed
- by Tim Povtak
- Asbestos Exposure & Bans
- Sep 2, 2020
The Science Advisory Committee on Chemicals found considerable failings and an underestimation of danger to the general public in a draft risk evaluation of asbestos submitted earlier this year…
Read More
Georgia-Pacific Pledges $1B to Bestwall Asbestos Trust Fund
- by Tim Povtak
- Asbestos Exposure & Bans
- Aug 25, 2020
Georgia-Pacific has pledged $1 billion to fund an asbestos trust for bankrupt affiliate Bestwall LLC, clearing the path to a settlement of longstanding liability claims involving mesothelioma cancer. Bloomberg…
Read More
